Senior Analyst, Global Life Sciences, EY
Ellen Licking is Senior Analyst for EY’s Global Life Sciences sector. Ellen has covered the life sciences industry for more than 15 years, first as a reporter at Business Week and then as an executive editor/writer for the biopharmaceutical group at Windhover Information and its acquirer, Elsevier. In October 2014, she joined EY after working two years as a reimbursement-focused analyst for the health care information start-up, Real Endpoints. While at EY, Ellen has worked closely with EY’s Life Sciences team on numerous biopharma and medtech reports including Progressions: Navigating the payer landscape, Beyond borders (biotech), Pulse of the Industry (medtech), and the EY Firepower and growth gap report.
The medical technology industry continues to respond to a number of key trends: the need to demonstrate value, the push to be more patient-centric, and the potential threat of commoditization. In this panel, EY will provide a preview of its yearly medtech report, Pulse of the Industry, explaining the year’s trends in the context of […]
From idea inception to commercialization, more and more start-ups are looking to large companies for strategic partnerships. This panel will explore the fundamental aspects needed to forge mutually beneficial relationships with large partners, such as collaborations, investments, licensing opportunities and in some cases M&A. Seasoned executives will share their perspective on the importance of relationships […]